The safety of abelacimab as compared with a direct oral anticoagulant in patients with atrial fibrillation is unknown. Patients with atrial fibrillation and a moderate-to-high risk of stroke were ...

Wave (iv) found robust support at $2,900, a key level reinforced by the 0.618 Fibonacci retracement of Wave (iii). This bounce also coincided with RSI recovery from oversold conditions ...

Gift 5 articles to anyone you choose each month when you subscribe. Fast-growing dark fibre player FibreconX is opening up its shareholder register for a new deep-pocketed investor, as it seeks to ...